dr. wolf on updated findings with capmatinib in metex14-mutant nsclc
Published 4 years ago • 450 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:44
dr. wolf on the design of geometry mono-1 trial in metex14-mutated nsclc
-
1:54
dr. le on the rationale for tepotinib in metex14-mutant nsclc
-
1:13
dr. reckamp on pivotal data in metex14-altered nsclc
-
2:38
dr. wolf discusses the geometry study in met nsclc
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
0:49
the importance of metex14 testing in nsclc
-
13:06
met exon 14 mutations in mnsclc
-
0:43
geometry study confirms importance of testing for metex14 alteration in advanced nsclc
-
2:40
dr. halmos on met mutations in patients with nsclc
-
2:49
the challenges of treating metex14 nsclc
-
13:46
dr navdeep singh | capmatinib unlocking the unmet need in metex14 skipping nsclc
-
2:24
dr. reckamp on met-targeting strategies in nsclc
-
2:48
new lung cancer test predicts survival
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
3:24
impact of met inhibitors in met exon 14-mutant nsclc
-
1:18
dr. lopategui on the evolution of targeted therapies in nsclc
-
3:01
update from chrysalis: amivantamab in patients with nsclc with met exon 14 skipping mutation
-
44:01
finding new components of the mammalian immune system | bruce beutler, md
-
2:31
biomarker testing in lung cancer | mark's perspective